There was minimal talaporfin incorporation in tumor-infiltrating CD4+ or CD8+ T cells in vivo, compared to its higher presence in nonimmune CD45- cells, which were predominantly tumor cells (Fig. 5A). This evidence concerns the gene CD8A and neoplasm.